Just as other industries are rolling back some consumer-friendly changes made early in the pandemic (think empty seats on airplanes), so too are health insurers.
Many voluntarily waived all deductibles, copayments and other costs for insured patients who fell ill with COVID-19 and needed hospital care, doctor visits, medications and other treatments.
But nothing lasts forever.
Starting at the end of last year and continuing into the spring a growing number of insurers are quietly ending those fee waivers for COVID-19 treatment on some or all policies. When it comes to treatment, more and more consumers will find that normal course of deductibles, copayments and coinsurance will apply.
What it all means.
Waivers may result in little savings for people with mild cases of COVID-19 that are treated at home. But the savings for patients who fall seriously ill and wind up in the hospital could be substantial. Consumers need to review claim statements (explanation of benefits) to determine if any cost sharing requirements apply for COVID-19 related medical charges.